Legislation

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

The Poisons Standard classifies medicines and poisons into different Schedules, signifying the degree of risk and the control recommended to be exercised over their availability to the public. Sometimes referred to as the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).

This Specification facilitates the release of de-identified adverse event report information recorded in the Adverse Event Management System (AEMS) portal to sponsors.

This Specification facilitates the release of specified kinds of therapeutic goods information relating to adverse events following immunisation to specified persons or bodies.

This Specification facilitates the publication of certain therapeutic goods information relating to complaints and investigations by the TGA in respect of the advertising of therapeutic goods and dissemination of generic information.

This Specification facilitates the public release of therapeutic goods information relating to advisory committee meetings.

This Specification facilitates the release of therapeutic goods information relating to advisory committee meetings to relevant persons or bodies for specified purposes.

This Specification facilitates the release of specified therapeutic goods information relating to adverse events following immunisation to specified persons or bodies.

This Declaration amends the Therapeutic Goods (Articles that are Not Medical Devices) Declaration 2023 to specify certain other therapeutic goods that are not medical devices for the purposes of the Therapeutic Goods Act 1989.

This Determination specifies a number of articles that are not medical devices for the purposes of the Therapeutic Goods Act 1989.

The legislation amends the rules for the authorised supply of unapproved therapeutic goods in Australia under the TGA's Special Access Scheme category C pathway.